4.6 Article

Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology

Hyun Tae Lee et al.

MOLECULES (2019)

Article Biochemistry & Molecular Biology

Rational design of anti-GITR-based combination immunotherapy

Roberta Zappasodi et al.

NATURE MEDICINE (2019)

Review Biochemistry & Molecular Biology

Mechanisms Controlling PD-L1 Expression in Cancer

Jong-Ho Cha et al.

MOLECULAR CELL (2019)

Review Medicine, Research & Experimental

Immunotherapeutic interventions of Triple Negative Breast Cancer

Zehuan Li et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong-Ho Cha et al.

MOLECULAR CELL (2018)

Article Medicine, General & Internal

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

P. Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Immunology

Coinhibitory Pathways in Immunotherapy for Cancer

Susanne H. Baumeister et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

Article Oncology

Deubiquitination and Stabilization of PD-L1 by CSN5

Seung-Oe Lim et al.

CANCER CELL (2016)

Review Oncology

Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives

Michael B. Atkins et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Multidisciplinary Sciences

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Chia-Wei Li et al.

NATURE COMMUNICATIONS (2016)

Review Oncology

Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives

Michael B. Atkins et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Review Oncology

Immune Checkpoint Blockade in Cancer Therapy

Michael A. Postow et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Oncology

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Otto Metzger-Filho et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Review Immunology

Coordinated regulation of myeloid cells by tumours

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Immunology

4-1BB signaling beyond T cells

Dass S. Vinay et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2011)

Review Immunology

Science gone translational: the OX40 agonist story

Andrew D. Weinberg et al.

IMMUNOLOGICAL REVIEWS (2011)

Article Medicine, Research & Experimental

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Biotechnology & Applied Microbiology

Targeting cancer metabolism: a therapeutic window opens

Matthew G. Vander Heiden

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Oncology

Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects

B. S. Dwarakanath et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)

Review Oncology

Basal-like breast cancer: A critical review

Emad A. Rakha et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Review Multidisciplinary Sciences

Intracellular functions of N-linked glycans

A Helenius et al.

SCIENCE (2001)